ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
The division provides a forum for focused technical dialogue on thermal hydraulic technology in the nuclear industry. Specifically, this will include heat transfer and fluid mechanics involved in the utilization of nuclear energy. It is intended to attract the highest quality of theoretical and experimental work to ANS, including research on basic phenomena and application to nuclear system design.
Conference on Nuclear Training and Education: A Biennial International Forum (CONTE 2021)
February 9–11, 2021
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Latest Journal Issues
Nuclear Science and Engineering
Fusion Science and Technology
Former NRC chairs issue vaccine timeline recommendation to CDC
Five former chairmen of the U.S. Nuclear Regulatory Commission—Stephen Burns, Allison Macfarlane, Nils Diaz, Richard Meserve, and Dale Klein—signed a letter to José Romero, Arkansas health secretary and chair of the Centers for Disease Control and Prevention (CDC) immunization advisory committee, requesting that the advisory committee update its recommendation for COVID-19 vaccine allocation guidance for the energy workforce (including nuclear energy workers).
Currently, the CDC has four phases for the COVID-19 vaccine rollout. Those phases are numbered:
Technical Session|Panel|Sponsored by IRD
Monday, November 16, 2020|12:00–2:10PM (1:00–3:10PM EST)
Lin-Wen Hu (MIT)
James Bowen (PNNL)
Rick Michal (American Nuclear Society)
Radioisotopes produced from nuclear reactors and accelerators are widely used for medical diagnostics and cancer therapy. For example, Tc-99m (decay product of Mo-99) is used in more than 80% of nuclear medicine diagnostic procedures. I-131 is widely used to treat thyroid cancer and applications of Lu-177 have increased in recent years for targeted therapy. This panel session will feature the following speakers to discuss the advancement and status of domestic production and applications of medical isotopes:
1) Peter J. Karcz: NNSA’s Mo-99 Program: Accelerating Reliable, Non-HEU Mo-99 Production Capabilities in the U.S.,
2) Greg Piefer: Progress at SHINE Medical in Commercializing Mo-99 and Lu-177 for Diagnostic and Therapeutic Applications,
3) Ira Goldman: Achieving Security of Supply of Medical Radioisotopes,
4) Les Foyto: MURR’s Role in Supplying Isotopes for Research and Patient Care, and
5) Jon Neuhoff: DOE Production of Radioisotopes for Medical Research, Diagnosis, and Treatment
To access the session recording, you must be logged in and registered for the meeting.
Register NowLog In
To access session resources, you must be logged in and registered for the meeting.
To join the conversation, you must be logged in and registered for the meeting.